Publications

Development of an RNA aptamer as a therapeutic agent for synucleinopathies

 39
Development of an RNA aptamer as a therapeutic agent for synucleinopathies

Tags:

Previous Article

Cognitive symptoms in cerebral palsy from remote network

Next Article

RNA aptamer to treat synucleinopathies

Related Posts

The role of nutrient stress in DNA damage

The role of nutrient stress in DNA damage

 108

Neurons undergo IFNγ-driven persistent epigenetic shifts and synaptopathy in encephalitis

Neurons undergo IFNγ-driven persistent epigenetic shift...

 88

Lentiviral vectors for hematopoietic stem cell gene therapy restore α-globin expression in α-thalassemia red blood cells

Lentiviral vectors for hematopoietic stem cell gene the...

 89